Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2018
Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV InfectionSteven Flamm, K Rajender Reddy, Neddie Zadeikis, et al.Hepatology (Baltimore, Md.)|September 27, 2007
Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trialIra M Jacobson, Robert S Brown, Bradley Freilich, et al.The Journal of Physiology|December 27, 2019
A porcine model for studying the cardiovascular consequences of high-thoracic spinal cord injuryChristopher R West, Malihe-Sadat Poormasjedi-Meibod, Neda Manouchehri, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 31, 2025
Role of Social Determinants and Outcomes of Patients with Alcohol-Associated Liver Disease Referred for Early Liver Transplantation: A Multicenter AnalysisBima J Hasjim, Anjana Rajan, Nivetha Saravanan, et al.Journal of Neurotrauma|July 22, 2020
Continuous Optical Monitoring of Spinal Cord Oxygenation and Hemodynamics during the First Seven Days Post-Injury in a Porcine Model of Acute Spinal Cord InjuryAmanda Cheung, Lorna Tu, Neda Manouchehri, et al.Cardiovascular and Interventional Radiology|April 7, 2021
Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient AnalysisMonica M Matsumoto, Samdeep Mouli, Priyali Saxena, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 7, 2025
Gender disparity in access to early liver transplant among patients with alcohol associated liver disease and limited sobriety is mediated by psychosocial factorsKatherine M Cooper, Ami K Patel, Alessandro Colletta, et al.Hepatology (Baltimore, Md.)|June 22, 2010
Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infectionAndrew J Muir, Mitchell L Shiffman, Atif Zaman, et al.Journal of Neurotrauma|April 3, 2020
Relationship between Early Vasopressor Administration and Spinal Cord Hemorrhage in a Porcine Model of Acute Traumatic Spinal Cord InjuryAmanda Cheung, Femke Streijger, Kitty So, et al.Journal of Hepatology|November 9, 2010
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ programThierry Poynard, Mona Munteanu, Massimo Colombo, et al.Pageof 6